Carboplatin in combination with weekly Paclitaxel as first-line therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma unfit to EXTREME schedule

The standard first-line treatment in recurrent/metastatic head and neck squamous cell carcinoma combines Cisplatin, 5 Fluorouracil and Cetuximab, but many patients aren’t eligible. We retrospectively evaluated the efficacy and the tolerability of Carboplatin and Paclitaxel in this indication, mostly...

Descripción completa

Detalles Bibliográficos
Autores principales: Pêtre, Adeline, Dalban, Cécile, Karabajakian, Andy, Neidhardt, Eve-Marie, Roux, Pierre Eric, Poupart, Marc, Deneuve, Sophie, Zrounba, Philippe, Fayette, Jérome
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955142/
https://www.ncbi.nlm.nih.gov/pubmed/29774120
http://dx.doi.org/10.18632/oncotarget.25157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955142/
https://www.ncbi.nlm.nih.gov/pubmed/29774120
http://dx.doi.org/10.18632/oncotarget.25157

Ejemplares similares